Evidence map›Paper›PMID 38190075›Full record

ReviewNano convergence2024

Rapid assays of SARS-CoV-2 virus and noble biosensors by nanomaterials.

Yang Liu, Yilong Li, Yuteng Hang, Lei Wang, Jinghan Wang, Ning Bao, Youngeun Kim, Ho Won Jang

Open access · diamondAbstract readReview
In one paragraph

Review in Nano convergence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 4 countries.

Yang LiuSchool of Public Health, Nantong University, Nantong, 226019, Jiangsu, People's Republic of China.
Yilong LiSchool of Public Health, Nantong University, Nantong, 226019, Jiangsu, People's Republic of China.
Yuteng HangSchool of Public Health, Nantong University, Nantong, 226019, Jiangsu, People's Republic of China.
Lei WangNantongEgens Biotechnology Co., LTD, Nantong, 226019, Jiangsu, People's Republic of China.
Jinghan WangDepartment of Materials Science and Engineering, Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, Republic of Korea.
Ning BaoSchool of Public Health, Nantong University, Nantong, 226019, Jiangsu, People's Republic of China.
Youngeun KimDepartment of Materials Science and Engineering, Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, Republic of Korea. youngeunkim@snu.ac.kr.
Ho Won JangDepartment of Materials Science and Engineering, Research Institute of Advanced Materials, Seoul National University, Seoul, 08826, Republic of Korea. hwjang@snu.ac.kr.ORCID http://orcid.org/0000-0002-6952-7359
Seoul National University · KRNantong University · CN

Funding

Basic Science Research Program of the National Research Foundation of Korea 2023-00208902Korea Institute for Advancement of Technology P0012770Nantong science and technology project JC22022105National Natural Science Foundation of China-Xinjiang Joint Fund 81202249
6 · The paper itself

Abstract

The COVID-19 outbreak caused by SARS-CoV-2 in late 2019 has spread rapidly across the world to form a global epidemic of respiratory infectious diseases. Increased investigations on diagnostic tools are currently implemented to assist rapid identification of the virus because mass and rapid diagnosis might be the best way to prevent the outbreak of the virus. This critical review discusses the detection principles, fabrication techniques, and applications on the rapid detection of SARS-CoV-2 with three categories: rapid nuclear acid augmentation test, rapid immunoassay test and biosensors. Special efforts were put on enhancement of nanomaterials on biosensors for rapid, sensitive, and low-cost diagnostics of SARS-CoV-2 virus. Future developments are suggested regarding potential candidates in hospitals, clinics and laboratories for control and prevention of large-scale epidemic.

Indexed as

BiosensorsNanomaterialsRapid assaysSARS-CoV-2 virus

Identifiers

PMID38190075
PMCPMC10774473
OpenAlexW4390666335

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.